3 ms·
Some of them we know why, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC452549/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC452549/ These are millions of peopl
by vasco 2y ago
Some of them we know why, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC452549/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC452549/
These are millions of people who are at elevated risk of soft tissue cancer because drug companies decided it'd be better to give contaminated medicines known to cause cancer later to developing countries populations. It's only one source but I recently became aware of this paper and it's a bit revolting.
- _heimdall 2y agoThat seems important, though unrelated here as the OP study only looked at cancer data in the US.
- vasco 2y agoIt might look like so at first glance but if you read the paper you will see the reason it was known that the US was exporting carcinogenic medicines is that before they knew, they were using it on americans. Millions of americans received the same medicines, then when they found out they were carcinogenic, instead of destroying those medicines the US gave them to developing countries to not let the stock go to waste.
- _heimdall 2y agoInteresting, yeah I missed that connection when skimming the paper. In this context its still important that the meds were given to Americans rather than developing countries, but that may be splitting hairs.
- consteval 2y agoInterestingly, this is exactly what Bayer pharmaceutical did with hemophilia medication during the AIDS crisis. They figured out their drug was contaminated with HIV so they stopped selling it to Americans. Instead, they sold it to developing countries.